Oncocytic-type intraductal papillary mucinous neoplasm (IPMN)-derived invasive oncocytic pancreatic carcinoma with brain metastasis - a case report

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Chiang, Kun Chun ^a,b   Yu, Chi Chang ^a   Chen, Jim Ray ^a   Huang, Yu Ting ^a   Huang, Cheng Cheng ^a   Yeh, Chun Nan ^a   Tsai, Chien Sheng ^a   Chen, Li Wei ^a   Chen, Hsien Cin ^a   Hsu, Jun Te ^a   Wang, Cheng Hsu ^a,c   Chen, Huang Yang ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Brain metastasis; IPMN; Oncocytic IPMN; Pancreatic cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; MUCIN;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER STAGING; CASE REPORT; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; FRONTAL LOBE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE ONCOCYTIC PANCREATIC CARCINOMA; LAPAROTOMY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; RADIATION DOSE; RIGHT SIDED WEAKNESS; TUMOR CELL; TUMOR VOLUME; WEAKNESS;

EID: 84863513133     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-138     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. Atlas of Tumor Pathology, 4th series, fascicle 6. Washington: Proceedings of the American Registry of Pathology 2007,
3. Grutzmann R, Niedergethmann M, Pilarsky C, Kloppel G, Saeger HD. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist 2010, 15:1294-1309. 10.1634/theoncologist.2010-0151, 10.1634/theoncologist.2010-0151, 3227924, 21147870.
4. Ohhashi K, Murakami Y, Maruyama M, Takekoshi T, Ohta H, Ohhashi I. Four cases of mucous secreting pancreatic cancer. Prog Dig Endosc 1982, 20:348-351.
5. Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Engl J Med 2004, 351:1218-1226. 10.1056/NEJMra031623 351/12/1218, 10.1056/NEJMra031623, 15371579.
6. Belyaev O, Seelig MH, Muller CA, Tannapfel A, Schmidt WE, Uhl W. Intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 2008, 42:284-294. 10.1097/MCG.0b013e3180500761.
7. Kloppel GES, Solcia E, Longnecker DS, Capella C, Sobin LH. World Health Organization. Institutional Histological Classification of Tumors. Histological Typing of Tumors of the Exocrine Pancreas 1996, Berlin: Springer-Verlag.
8. Obara T, Maguchi H, Saitoh Y, Itoh A, Arisato S, Ashida T, Nishino N, Ura H, Namiki M. Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes. Am J Gastroenterol 1993, 88:564-569.
9. Levy P, Jouannaud V, O'Toole D, Couvelard A, Vullierme MP, Palazzo L, Aubert A, Ponsot P, Sauvanet A, Maire F, Hentic O, Hammel P, Ruszniewski P. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol 2006, 4:460-468. 10.1016/j.cgh.2006.01.018], 10.1016/j.cgh.2006.01.018, 16616351.
10. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004, 239:788-797. discussion 797-789, 10.1097/01.sla.0000128306.90650.aa, 1356287, 15166958.
11. D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 2004, 239:400-408. 10.1097/01.sla.0000114132.47816.dd, 1356240, 15075659.
12. Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 2006, 13:582-594. 10.1245/ASO.2006.05.002, 10.1245/ASO.2006.05.002, 16523362.
13. Z'Graggen K, Rivera JA, Compton CC, Pins M, Werner J. Fernandez-del Castillo C, Rattner DW, Lewandrowski KB, Rustgi AK, Warshaw AL: Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997, 226:491-498. discussion 498-500, 10.1097/00000658-199710000-00010, 1191067, 9351717.
14. Salvia R, Fernandez-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004, 239:678-685. discussion 685-677, 10.1097/01.sla.0000124386.54496.15, 1356276, 15082972.
15. Mino-Kenudson M, Fernandez-Del Castillo C, Baba Y, Valsangkar NP, Liss AS, Hsu M, Correa-Gallego C, Ingkakul T, Johnston RP, Turner BG, Androutsopoulos V, Deshpande V, McGrath D, Sahani DV, Brugge WR, Ogino S, Pitman MB, Warshaw AL, Thayer SP. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011, 60:1712-1720. 10.1136/gut.2010.232272, 10.1136/gut.2010.232272, 21508421.
16. Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma. Pancreas 2006, 32:281-287. 10.1097/01.mpa.0000202955.33483, 10.1097/01.mpa.0000202955.33483.e2, 16628084.
17. Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Levy P, Belghiti J, Ruszniewski P. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002, 51:717-722. 10.1136/gut.51.5.717, 1773420, 12377813.
18. Yopp AC, Katabi N, Janakos M, Klimstra DS, D'Angelica MI, DeMatteo RP, Fong Y, Brennan MF, Jarnagin WR, Allen PJ. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg 2011, 253:968-974. 10.1097/SLA.0b013e318214bcb4, 10.1097/SLA.0b013e318214bcb4, 21422912.
19. Hidalgo M. Pancreatic cancer. N Engl J Med 2010, 362:1605-1617. 10.1056/NEJMra0901557, 10.1056/NEJMra0901557, 20427809.
20. Lee YT, Tatter D. Carcinoma of the pancreas and periampullary structures, Pattern of metastasis at autopsy. Arch Pathol Lab Med 1984, 108:584-587.
21. Shangai VA, Gavrik Iu V. Metastasis of pancreatic cancer to the brain. Vrach Delo 1984, 11:77-79.
22. Olson ME, Chernik NL, Posner JB. Infiltration of the leptomeninges by systemic cancer, A clinical and pathologic study. Arch Neurol 1974, 30:122-137. 10.1001/archneur.1974.00490320010002, 4405841.
23. Caricato M, Borzomati D, Ausania F, Garberini A, Rabitti C, Tonini G, Coppola R. Cerebellar metastasis from pancreatic adenocarcinoma. A case report. Pancreatology 2006, 6:306-308. 10.1159/000092693, 10.1159/000092693, 16636605.
24. Renouf D, Moore M. Evolution of systemic therapy for advanced pancreatic cancer. Expert Rev Anticancer Ther 2010, 10:529-540. 10.1586/era.10.21, 10.1586/era.10.21, 20397918.
25. Vazquez BJ, Richards ML, Lohse CM, Thompson GB, Farley DR, Grant CS, Huebner M, Moreno J. Adrenalectomy improves outcomes of selected patients with metastatic carcinoma. World J Surg 2012, 36:1400-1405. 10.1007/s00268-012-1506-3, 22411083.
26. Huguet F, Andre T, Hammel P, Artru P, Balosso J, Selle F, Deniaud-Alexandre E, Ruszniewski P, Touboul E, Labianca R, de Gramont A, Louvet C. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 2007, 25:326-331. 10.1200/JCO.2006.07.5663, 10.1200/JCO.2006.07.5663, 17235048.
27. Sultana A, Tudur Smith C, Cunningham D, Starling N, Tait D, Neoptolemos JP, Ghaneh P. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Br J Cancer 2007, 96:1183-1190. 10.1038/sj.bjc.6603719, 10.1038/sj.bjc.6603719, 2360143, 17406358.
28. Carter SK, Comis RL. The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma. Cancer Treat Rev 1975, 2:193-214. 10.1016/S0305-7372(75)80003-X, 1104163.
29. Cullinan S, Moertel CG, Wieand HS, Schutt AJ, Krook JE, Foley JF, Norris BD, Kardinal CG, Tschetter LK, Barlow JF. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer 1990, 65:2207-2212. 10.1002/1097-0142(19900515)65:10<2207::AID-CNCR2820651007>3.0.CO;2-Y, 2189551.